XENPOZYME

We will be changing our web hosting provider during the next few days.

During this time, the site may work slowly or be unavailable.

We apologize for the inconvenience and kindly ask you to be patient!

Google image searchProduct monograph

Active ingredient

olipudase alfa, 20 MG/VIAL

DIN: 02545721

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 18-OCT-2024

ATC:

A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
A16AB — Enzymes (ATC, ATC/DDD)
A16AB25 — OLIPUDASE ALFA (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Xenpozyme

Search on Google

Xenpozyme side effects
Xenpozyme dosage
olipudase alfa side effects
olipudase alfa dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find xenpozyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.